- Home
- CHT vs IQV Comparison
CHT vs IQV Comparison
Compare CHT & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHT
- IQV
- Stock Information
- Founded
- CHT 1996
- IQV 1982
- Country
- CHT Taiwan
- IQV United States
- Employees
- CHT N/A
- IQV N/A
- Industry
- CHT Telecommunications Equipment
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CHT Telecommunications
- IQV Health Care
- Exchange
- CHT Nasdaq
- IQV Nasdaq
- Market Cap
- CHT 30.5B
- IQV 31.6B
- IPO Year
- CHT 2003
- IQV 2013
- Fundamental
- Price
- CHT $39.96
- IQV $143.91
- Analyst Decision
- CHT
- IQV Strong Buy
- Analyst Count
- CHT 0
- IQV 19
- Target Price
- CHT N/A
- IQV $240.79
- AVG Volume (30 Days)
- CHT 150.0K
- IQV 2.4M
- Earning Date
- CHT 05-01-2025
- IQV 05-01-2025
- Dividend Yield
- CHT 3.69%
- IQV N/A
- EPS Growth
- CHT 0.71
- IQV 2.74
- EPS
- CHT 0.15
- IQV 7.49
- Revenue
- CHT $7,015,506,083.00
- IQV $15,405,000,000.00
- Revenue This Year
- CHT $3.15
- IQV $4.14
- Revenue Next Year
- CHT $1.75
- IQV $6.08
- P/E Ratio
- CHT $26.79
- IQV $19.21
- Revenue Growth
- CHT 3.03
- IQV 2.81
- 52 Week Low
- CHT $35.92
- IQV $135.97
- 52 Week High
- CHT $40.62
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- CHT 57.14
- IQV 31.72
- Support Level
- CHT $37.52
- IQV $135.97
- Resistance Level
- CHT $40.29
- IQV $152.48
- Average True Range (ATR)
- CHT 0.98
- IQV 9.22
- MACD
- CHT 0.11
- IQV -1.08
- Stochastic Oscillator
- CHT 87.99
- IQV 18.95
About CHT Chunghwa Telecom Co. Ltd.
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company segment consists of Consumer Business, Enterprise Business, International Business, and Others. The company generates the majority of its revenue from the Consumer Business segment. The consumer Business segment generates revenue from Mobile services, Fixed-line services, Sales, and others.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.